Outcomes following liver transplantation in intensive care unit patients

Table 1 Patient, operative and donor characteristics in intensive care unit and non-intensive care unit patients

Variable	ICU patients(n = 39)	Non-ICU patients(n = 927)	P value
Patient characteristics
Age at transplant	57 (33-74)	57 (16-77)	0.91
Gender (male)	21 (54%)	653 (70%)	0.033
BMI	25.7 (18.0-38.0)	28.4 (16.4-61.1)	0.091
Diagnosis
Hepatitis C	18 (46%)	364 (41%)	0.41
ETOH	10 (26%)	138 (15%)	0.11
Cryptogenic cirrhosis	8 (21%)	147 (16%)	0.5
NASH	0 (0%)	76 (8%)	0.066
PSC	0 (0%)	61 (7%)	0.17
Other	3 (8%)	141 (15%)	0.25
MELD at transplant	37 (24-50)	20 (6-45)	< 0.001
Previous operation	13 (34%)	402 (47%)	0.13
Operative characteristics
Operative time (min)	230 (129-596)	231 (100-745)	0.69
Blood transfusion (mL)	3850 (1400-15 400)	2800 (0-44 100)	0.002
Cold ischemia time (h)	6.3 (3.4-10.4)	6.3 (2.0-14.0)	0.71
Warm ischemia time (min)	30 (18-84)	31 (10-141)	0.59
Donor characteristics
Age	42 (8-78)	48 (7-88)	0.016
Gender (male)	17 (46%)	551 (59%)	0.12
Recipient-donor gender incompatibility	15 (41%)	348 (38%)	0.73
Donation after cardiac death	6 (16%)	146 (16%)	1.00
Donor risk index	1.53 (0.88-2.60)	1.66 (0.85-4.30)	0.085

The sample median (minimum-maximum) is given for numerical variables. P values result from Fisher’s exact test or a Wilcoxon rank sum test. Information was unavailable regarding previous operations (ICU: n = 1; non-ICU: n = 80), operative time (ICU: n = 2; non-ICU: n = 1), blood transfusion (ICU: n = 3; non-ICU: n = 13), cold ischemia time (ICU: n = 2), warm ischemia time (ICU: n = 2), and all donor characteristics (ICU: n = 2). ICU: Intensive care unit; BMI: Body mass index; ETOH: Ethanol; NASH: Nonalcoholic steatohepatitis; PSC: Primary sclerosing cholangitis; MELD: Model for end-stage liver disease.